BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14556625)

  • 1. Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101).
    Strickler M; Goldstein BM; Maxfield K; Shireman L; Kim G; Matteson DS; Jones JP
    Biochemistry; 2003 Oct; 42(41):11943-50. PubMed ID: 14556625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural evidence for a functionally relevant second camphor binding site in P450cam: model for substrate entry into a P450 active site.
    Yao H; McCullough CR; Costache AD; Pullela PK; Sem DS
    Proteins; 2007 Oct; 69(1):125-38. PubMed ID: 17598143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam.
    Bell SG; Chen X; Sowden RJ; Xu F; Williams JN; Wong LL; Rao Z
    J Am Chem Soc; 2003 Jan; 125(3):705-14. PubMed ID: 12526670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role of the heme-7-propionate side chain in cytochrome P450cam as a gate for regulating the access of water molecules to the substrate-binding site.
    Hayashi T; Harada K; Sakurai K; Shimada H; Hirota S
    J Am Chem Soc; 2009 Feb; 131(4):1398-400. PubMed ID: 19133773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity correlations in pentachlorobenzene oxidation by engineered cytochrome P450cam.
    Xu F; Bell SG; Rao Z; Wong LL
    Protein Eng Des Sel; 2007 Oct; 20(10):473-80. PubMed ID: 17962225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoreduction EPR and 13C, 19F ENDOR study of substrate-bound substates and solvent kinetic isotope effects in the catalytic cycle of cytochrome P450cam and its T252A mutant.
    Kim SH; Yang TC; Perera R; Jin S; Bryson TA; Sono M; Davydov R; Dawson JH; Hoffman BM
    Dalton Trans; 2005 Nov; (21):3464-9. PubMed ID: 16234926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrared spectroscopic and mutational studies on putidaredoxin-induced conformational changes in ferrous CO-P450cam.
    Nagano S; Shimada H; Tarumi A; Hishiki T; Kimata-Ariga Y; Egawa T; Suematsu M; Park SY; Adachi S; Shiro Y; Ishimura Y
    Biochemistry; 2003 Dec; 42(49):14507-14. PubMed ID: 14661963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alcohols on binding of camphor to cytochrome P450cam: spectroscopic and stopped flow transient kinetic studies.
    Murugan R; Mazumdar S
    Arch Biochem Biophys; 2006 Nov; 455(2):154-62. PubMed ID: 17049478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of P450cin in a complex with its substrate, 1,8-cineole, a close structural homologue to D-camphor, the substrate for P450cam.
    Meharenna YT; Li H; Hawkes DB; Pearson AG; De Voss J; Poulos TL
    Biochemistry; 2004 Jul; 43(29):9487-94. PubMed ID: 15260491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dithionite reduced carbon monoxide complex of cytochrome P450cam is a monomer.
    Behlke J; Jung C
    Biochem Biophys Res Commun; 1998 Dec; 253(3):558-60. PubMed ID: 9918766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural stability and dynamics of hydrogenated and perdeuterated cytochrome P450cam (CYP101).
    Meilleur F; Contzen J; Myles DA; Jung C
    Biochemistry; 2004 Jul; 43(27):8744-53. PubMed ID: 15236583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P450cam visits an open conformation in the absence of substrate.
    Lee YT; Wilson RF; Rupniewski I; Goodin DB
    Biochemistry; 2010 Apr; 49(16):3412-9. PubMed ID: 20297780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-scan time-resolved FTIR spectroscopy of cytochrome P-450cam carbon monoxide complex: a salt link involved in the ligand-rebinding process.
    Contzen J; Jung C
    Biochemistry; 1998 Mar; 37(13):4317-24. PubMed ID: 9556346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state kinetic investigation of cytochrome P450cam: interaction with redox partners and reaction with molecular oxygen.
    Purdy MM; Koo LS; Ortiz de Montellano PR; Klinman JP
    Biochemistry; 2004 Jan; 43(1):271-81. PubMed ID: 14705955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pressure fourier transform infrared (FT-IR) spectroscopic studies on inducible nitric oxide (NO) synthase active site: a comparison to cytochrome p450CAM.
    Jung C; Ghosh DK
    Cell Mol Biol (Noisy-le-grand); 2004 Jun; 50(4):335-46. PubMed ID: 15529743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate modulation of the properties and reactivity of the oxy-ferrous and hydroperoxo-ferric intermediates of cytochrome P450cam as shown by cryoreduction-EPR/ENDOR spectroscopy.
    Davydov R; Perera R; Jin S; Yang TC; Bryson TA; Sono M; Dawson JH; Hoffman BM
    J Am Chem Soc; 2005 Feb; 127(5):1403-13. PubMed ID: 15686372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for effector activity in a highly specific biological electron transfer complex: the cytochrome P450(cam)-putidaredoxin couple.
    Pochapsky SS; Pochapsky TC; Wei JW
    Biochemistry; 2003 May; 42(19):5649-56. PubMed ID: 12741821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of CYP101D2 unveils a potential path for substrate entry into the active site.
    Yang W; Bell SG; Wang H; Zhou W; Bartlam M; Wong LL; Rao Z
    Biochem J; 2011 Jan; 433(1):85-93. PubMed ID: 20950270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A mutation.
    Verras A; Alian A; de Montellano PR
    Protein Eng Des Sel; 2006 Nov; 19(11):491-6. PubMed ID: 16943206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.